Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis
CNS Neuroscience & Therapeutics · 2025-07 · 31 (7)
DOI: 10.1111/cns.70537 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 28.07.2025. Verfasst von Xin Jin und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China,…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Glucose, Nerve Net, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Scientific Research Program of FuRong Laboratory, Project Program of National Clinical Research Center for Geriatric Disorders.
Abstract (Originalsprache)
Aims
This study aimed to characterize the topological changes in glucose metabolism covariance networks in amyotrophic lateral sclerosis (ALS).
Methods
We assessed the interregional coordination of 18 F‐FDG‐PET data to examine topological alterations in individualized glucose metabolism covariance networks in 127 ALS patients compared to 128 healthy controls (HC).
Results
Compared to HC, ALS patients showed reduced small‐worldness (lower normalized clustering coefficient, higher normalized characteristic path length) and decreased global and local efficiency, suggesting impaired global integration and local segregation. These network metrics correlated with disease progression and motor function. Regionally, altered degree centrality affected motor and default mode networks, and related to GABAa and mGluR5 receptor expression. Transcriptomic associations further linked these changes to immune function, synaptic signaling, and protein regulation. Bidirectional shifts in connectivity strength were observed, with both increased connectivity and disease progression independently predicting reduced survival.
Conclusion
Our findings may provide valuable biomarkers for monitoring the progression of ALS and suggest potential mechanistic pathways for the development of innovative therapeutic strategies for this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
- School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
- Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
- Douglas Mental Health University Institute, McGill University, Montreal, Quebec, Canada.
- Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, Jiangxi, P. R. China.
- Department of Psychology and Cognitive Sciences (DiPSCo), University of Trento, Rovereto, Italy.
ORCID-Profile: Xueying Wang, Jinfan Zhang, Alessandro Grecucci, Yuanchao Zhang, Junling Wang, Xiaoping Yi, Lena Palaniyappan
Förderung
- National Natural Science Foundation of China
- The Scientific Research Program of FuRong Laboratory
- Project Program of National Clinical Research Center for Geriatric Disorders
- Fundamental Research Funds for the Central Universities of Central South University
- Fonds de Recherche du Québec - Santé
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Jin, X., Wang, X., Zheng, D., Yuan, P., Li, J., Qiu, T., Zhang, H., Chen, Y., Zhang, J., Wu, F., Liu, Q., Grecucci, A., Zhang, Y., Wang, J., Yi, X., Palaniyappan, L., & Braden, B. B. (2025). Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis. CNS Neuroscience & Therapeutics, 31(7). https://doi.org/10.1111/cns.70537
Vancouver
Jin X, Wang X, Zheng D, Yuan P, Li J, Qiu T, et al. Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis. CNS Neuroscience & Therapeutics. 2025;31(7). doi:10.1111/cns.70537
BibTeX
@article{Jin2025,
author = {Jin, Xin and Wang, Xueying and Zheng, Dingxin and Yuan, Pubing and Li, Jianyu and Qiu, Ting and Zhang, Huixiong and Chen, Yifan and Zhang, Jinfan and Wu, Feifei and Liu, Qing and Grecucci, Alessandro and Zhang, Yuanchao and Wang, Junling and Yi, Xiaoping and Palaniyappan, Lena and Braden, B Blair},
title = {Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {7},
doi = {10.1111/cns.70537}
}
EUVIMED